CBT-I vs Sleeping Pills: Which Is Better for Insomnia?

If you've ever seen a GP about insomnia, you've probably been offered sleeping pills — zopiclone, temazepam, or more recently melatonin. They work fast, they're familiar, and they're easy to prescribe. But they're not the first-line recommendation anymore.

The NHS, NICE, and the American College of Physicians all now recommend CBT-I (Cognitive Behavioural Therapy for Insomnia) as the first treatment to try for chronic insomnia — before medication. Here's what the evidence shows when you compare the two directly.

What sleeping pills actually do

Most sleeping pills work by sedating your central nervous system — they don't produce natural sleep, they produce a sedated state that resembles sleep. The architecture is different: you spend less time in restorative deep sleep and REM, meaning you can wake up feeling groggy even after a full night.

The main types prescribed in the UK:

• ✓Z-drugs (zopiclone, zolpidem) — Fast-acting and effective short-term. NICE recommends using them for no longer than 2–4 weeks due to tolerance and dependence risk.
• ✓Benzodiazepines (temazepam, nitrazepam) — Older class, similar mechanism. Carry significant addiction risk with longer-term use.
• ✓Melatonin — Hormone supplement that regulates the sleep-wake cycle. Useful for jet lag and circadian rhythm issues, less effective for sleep-maintenance insomnia.
• ✓Antihistamines (diphenhydramine, promethazine) — Found in many over-the-counter sleep aids. Tolerance develops within days, and they cause significant morning sedation.

What the evidence shows

Short-term (2–4 weeks): sleeping pills win. They work faster, with less effort required from the person taking them. Time to fall asleep improves significantly within days.

Medium and long-term: CBT-I wins — substantially. A landmark meta-analysis published in the British Medical Journal found that CBT-I produced larger improvements in sleep onset, wake time after sleep onset, and overall sleep quality than medication, and those improvements held at 6-month and 12-month follow-up.

Most importantly: when you stop taking sleeping pills, the insomnia returns. When you complete CBT-I, the improvement typically holds. You're treating a cause, not managing a symptom.

The rebound problem

One of the most significant issues with sleeping pills is rebound insomnia — when you stop taking them, sleep often gets worse than it was before you started. This makes it hard to know whether the medication is actually helping or simply delaying the problem.

CBT-I has the opposite trajectory. Results tend to compound: by 8–12 weeks after completing a programme, many people sleep better than during it, because the habits become automatic and the anxiety around sleep reduces further over time.

Are sleeping pills ever the right choice?

Yes — in specific contexts. Short-term insomnia triggered by a bereavement, illness, or acute stress is a reasonable candidate for brief medication use. Circadian rhythm disorders may respond well to melatonin. People who cannot engage with CBT-I (due to cognitive difficulties or severe depression) may need medication while other treatment is stabilised.

But for chronic insomnia — ongoing trouble sleeping more than 3 nights per week, for more than 3 months — the evidence overwhelmingly supports CBT-I as the treatment of choice.

What to do if you are currently on sleeping pills

Don't stop suddenly. If you've been taking sleeping pills regularly, stopping abruptly can cause rebound insomnia and, with benzodiazepines, withdrawal symptoms. Talk to your GP about a tapering plan.

CBT-I can be started while still taking medication and has been shown to be effective even in people tapering off sleeping pills — in fact, CBT-I is an evidence-based support tool for medication withdrawal. Lunara's CBT-I programme is designed to run alongside any changes you're making with your GP.